Opus Genetics has reported early findings from its ongoing Phase I/II clinical trial of the OPGx-BEST1 gene therapy to treat ...

Medtech companies like BlueWind or Medtronic are increasingly investing in neuromodulation to treat urgency urinary ...

MSD has announced findings from the pivotal Phase III LITESPARK-022 trial, assessing the Keytruda-Welireg combination as adjuvant therapy for patients with clear cell RCC after nephrectomy.

Faster and more cost-effective trials support early-stage research in China driving the country's drug discovery engine.

Mahzi Therapeutics has dosed the first patient in its Phase I/II UNITE study assessing MZ-1866, an investigational gene ...

Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.

Novo Nordisk and United Laboratories’ jointly developed triple G drug has achieved a 19.7% weight loss in a Phase II trial in ...

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, ...

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of orforglipron and oral semaglutide in adults with type 2 diabetes ...

Synthekine has entered into a clinical trial partnership and supply agreement with MSD to investigate STK-012 in combination with Keytruda and chemotherapy in patients with first-line, PD-L1 negative ...

Jaguar Gene Therapy has completed Cohort I dosing of its first-in-human clinical trial investigating JAG201 for patients with SHANK3 haploinsufficiency.

The FENhance 1 and 2 trials involved 1,497 adults with RMS. Credit: New Africa / Shutterstock.com. Roche has reported that the pivotal Phase III FENhance 1 trial of its investigational Bruton’s ...